ANG and infectious disease: Even though the activity of Angie1 against extracellular Mtb is lower as compared to Angiogenin the abovementioned benefits regarding the potential stability, specificity and availability make Angie1 the superior candidate for further evaluation in in vivo models of infectious diseases.